Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-16-101365)

Filing Details

Accession Number:: 0001144204-16-101365
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-12 18:10:51
Reporting Period:: 2016-05-12

Filing Date:: 2016-05-12
Accepted Time:: 2016-05-12 18:10:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1430306	Tonix Pharmaceuticals Holding Corp.	TNXP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1180469	Ernest Mario	C/O Tonix Pharmaceuticals Holding Corp. 509 Madison Avenue, Suite 306 New York NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2016-05-12	31,042	$2.30	380,724	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.298749. The range of purchase prices on the transaction date was $2.285 to $2.30 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.